Last week was the best in several weeks.

We went 7 up, 5 down and 1 even this past week. But our model portfolio year-to-date gain fell a tad (.1%) to 11.0%. MIVA is still our biggest dog, followed by DWCH, LINN.ob.
OPTO.ob and ARIS.ob keep fluctuating between a small loss and a small gain. Since the start of the year we are 11 up and 5 down. OPTO.ob dropped back into the red on earnings but SPNC roared back into the plus column.

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

SPNC-(Buy price $10.65, Valuation $18-$20). Price jumped to $11.26, up $1.18 last week. Now up 6%. SPNC presents at a AG Edwards conference on September 20th at 10 am EST. Hopefully they will do good and we will get some buying interest and send the shorts running. HOLD

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.16 at $9.80. Yield about 3%. A group called Costa Brava Partnership offerred to buy the Class A stock at a “substantial premium”. The company has rejected this offer. CB owns 7.9% of the stock. CAW announced a $25 million credit line recently–so either some shares are going to get bought back or maybe an acquisition in the works? Up 4% so far. HOLD.

QADI-(Buy price $6.93, Valuation $13.73 (was $11.86). Closed at $7.42, up $.08. Yield about 1.4%. Trading at only 54% of valuation. Has $1.30 in cash also. Up 7% so far. BUY.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $19.36, up $.14. Now up .3%. HOLD.

MIVA-(Buy price $3.80, Valuation $7.38 (was $9.10)). MIVA closed up at $2.80. Now down 26% on this one. No news. BUY.

DWCH-(Buy price $3.66, Valuation $7.63 (was $9.31)). Closed at $2.79, up $.01, still a loser–down 24%. HOLD.

INFT-(Buy price $4.11, Valuation $6.86 (was $7.32)). Down $.17 to $4.14. Still has $2.52 per share in cash. Price objective $5.50. Now up about 1%. HOLD.

OB-abies

ARIS.ob-(Buy price $2.06, Valuation $5.21). Closed at $2.05, up $.05. Down .5% so far. BUY if you can find some shares. Huge valuation gap.

Linn.ob-(Buy price $.36, Valuation $.66 (was $.79)). Closed at $.31, even for the week. Still trading at less than 50% of our current valuation. Down 14% YTD. HOLD until we get some revenue growth and stop losing money.

OPTO.ob-(Buy price $1.25, Valuation $2.54 (was 2.88)). Closed at $1.20, down $.13. OPTO released earnings last week. Not what we hoped for, but not a disaster either. Sales were down 8%, due to some delayed sales (so they say) and they lost $450,000. They have cash of $.35 per share, 74% gross margins and a new valuation of $2.54 a share. We don’t like when our vluations fall, but there is still enough of a discount on this one to continue holding. Also, on the same day as earnings, they announced a sale to Ingersoll Rand. Now down 4% to date. HOLD.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock closed at $1.65, down $.05. Now only up 39%. Still waiting on year-end results for AVSO. Could be burdened with some acquisition and capital raising charges, but we expect to see some good operating results. Still only trading at less than 50% of our valuation. BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $1.05 (Was $.82)). Ask price stayed at $.35. Closed at $.33. Cash is $.28 per share. Up 30% (based on asked price). If you own this HOLD. If you don’t-BUY.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed up $.04 at $2.54, still up 33% so far. HOLD.

This cappy market is relentless.

We went 2 up, 9 down and 2 even this past week. Our model portfolio year-to-date gain dropped 3.1% to a 11.1% gain. MIVA is still our biggest dog, followed by DWCH, LINN.ob. Since the start of the year we are 10 up and 6 down, which stinks for us. PDLI dropped back into the red as did our latest recommedation SPNC last week.

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

As a side note, when tech related takeovers are announced, we test our valuation method against the take-0ver offer pricing. Last week EMBT had a takeover announced. We ran our valuation and came up with $8.11 a share. The takeover offer was $8.38. EMBT was trading at about $6.40 a share before the takeover or a 30% discount to the offer. Not enough of a discount for us to recommend this stock, but good validation that our method does work.

SPNC-(Buy price $10.65, Valuation $18-$20). The shorts continue to rule by constantly offering 100 share lots at lower and lower prices. Most of the time the same market makers are on the bid too–at lower and lower prices. Price fell to $10.08, down $.57 last week. Down 5%. SPNC presents at a AG Edwards conference on September 20th at 10 am EST. Hopefully they will do good and we will get some buying interest to knock off these 100 share trades. BUY

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.03 at $9.96. Yield about 3%. A group called Costa Brava Partnership offerred to buy the Class A stock at a “substantial premium”. The company has rejected this offer. CB owns 7.9% of the stock. CAW announced a $25 million credit line last week–so either some shares are going to get bought back or maybe an acquisition in the works? Up 5% so far. HOLD.

QADI-(Buy price $6.93, Valuation $13.73 (was $11.86). Closed at $7.34, down $.26. Yield about 1.4%. Trading at only 53% of valuation. Has $1.30 in cash also. Declared their quartely $.025 dividend last week. Up 6% so far. BUY.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $19.22, down $.62. Now down .5%. HOLD.
MIVA-(Buy price $3.80, Valuation $7.38 (was $9.10)). MIVA closed at $2.60, up $.06. Now down 32% on this one. No news. BUY.

DWCH-(Buy price $3.66, Valuation $7.63 (was $9.31)). Closed at $2.78, down $.15, still a loser–down 24%. HOLD.

INFT-(Buy price $4.11, Valuation $6.86 (was $7.32)). Up $.16 to $4.31. Still has $2.52 per share in cash. Price objective $5.50. Now up 5%. HOLD.

OB-abies

ARIS.ob-(Buy price $2.06, Valuation $5.21). Closed at $2.00, down $.05. Down 3% so far. BUY if you can find some shares. Huge valuation gap.

Linn.ob-(Buy price $.36, Valuation $.66 (was $.79)). Closed at $.31, down $.01. Still trading at less than 50% of our current valuation. Down 14% YTD. HOLD until we get some revenue growth and stop losing money.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.33, down $.07. Now up 6% to date. HOLD.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock closed at $1.70, down $.01. Now only up 43%. Still waiting on year-end results for AVSO. Could be burdened with some acquisition and capital raising charges, but we expect to see some good operating results. Still only trading at less than 50% of our valuation. BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $1.05 (Was $.82)). Ask price fell $.02 to $.35. Closed at $.34. Cash is $.28 per share. Up 30% (based on asked price). If you own this HOLD. If you don’t-BUY.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed unchanged at $2.50, still up 31% so far. HOLD.

SPNC is a medical company that sells laser equipment that helps clear blocked heart arteries, remove pacemaker leads and now can perform procedures to clear blocked leg arteries below the knee.

This last procedure has been helping people that formerly could only look forward to amputation and is what has been fueling SPNC’s recent sales growth.

SPNC has about $1.80 in cash, no debt, is growing sales at a 50% rate and is slightly profitable. Sales this year are expected to reach over $60 million and to be profiable on a non-GAAP basis. Gross margins are in the 70%+ range.

This one defies our normal valuation method as the market value (less cash) is at about 4.5 times revenues which is high–but not for a medical device maker with these margins and propects.

SPNC is also working to get approval to work on arteries above the knee (like Foxhollow-FOXH) which hopefully will come next year. Analysts are guessing at $80 million of revenue next year.

For reference, Luminex, another company with a similar model (sell machines that consume disposable high margin products) had sales of $13.3 million in the last quarter compared to SPNC’s $16 million, has $48 million in cash versus SPNC’s $56 million, has margins in the high 50% range verus 70%, has analyst predicted sales of $70 million next year—sells at 10 times revenues (adjusted for cash on hand).

Lastly, short sellers have been gnawing at SPNC. The stock has been pushed down to the current level from over $13 just recently as short interest has climbed. We think that this could be a $18 stock in the next 6-8 months. We have been in this stock for a long time and think this is a good buying opportunity. BUY.

Summer vacation last week.

We went 5 and 7 over the last 2 weeks. While the markets in general have been doing well over the last couple of weeks, this has not translated to our mini-cap stocks—yet. Our model portfolio year-to-date gain dropped .8% to a 14.2% gain–still better than all the indexes, but not where we want to be. MIVA is still our biggest dog, followed by DWCH, LINN.ob. Since the start of the year we are 11 up and 4 down.

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

ARIS-(Buy price $2.06, Valuation $5.21). Closed at $2.05, down $.01. Announced another expanded customer relationship and nothing happened. All these customer wins should translate into continued revenue and earnings improvements. At some point investors will take notice and this will take-off–we believe. Down .5% so far. BUY if you can find some shares.

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.01 at $9.99. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. The company has rejected this offer. The company is “in-play”. CB owns 7.9% of the stock. No news last week on anything. Up 6% so far. HOLD.

QADI-(Buy price $6.93, Valuation $13.73 (was $11.86). Closed at $7.60, down $.01. Trading at only 55% of valuation. Has $1.30 in cash also. Up 10% so far. BUY.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $19.84, up $1.45. Now up 3%. Nice to be in the plus column on this one finally. News last week that one drug partnership was canceled, but the stock went up. I think the expectation is that expenses will be reduced and profitability will increase. HOLD.

MIVA-(Buy price $3.80, Valuation $7.38 (was $9.10)). MIVA closed at $2.54, up $.19. Now down 33% on this one. No news. BUY.

Datawatch-(Buy price $3.66, Valuation $7.63 (was $9.31)). Closed at $2.93, up $.08, still a loser–down 20%. HOLD.

Inforte-(Buy price $4.11, Valuation $6.86 (was $7.32)). Down $.07 to $4.15. Still has $2.52 per share in cash and valuation only fell a little, but lowering our price objective to $5.50. Now up 1%. BUY.

OB-abies

Linn.ob-(Buy price $.36, Valuation $.66 (was $.79)). Closed at $.32, up $.01. Still trading at less than 50% of our current valuation. Down 11% YTD. Volume seems to be picking up and we are still seeing some sizable bids for 50,000–75,000 shares from time-to-time. HOLD until we get some revenue growth and stop losing money.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.40, up $.20. Now up 12% to date. HOLD.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock closed at $1.71), down $.09 from $1.80. Now only up 44%. Waiting on year-end results for AVSO. Could be burdened with some acquisition and capital raising charges, but we expect to see some good operating results. Still only trading at 50% of our valuation. BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $1.05 (Was $.82)). Ask price stayed at $.37. Closed at $.34. Cash is $.28 per share. Up 37% (based on asked price). If you own this HOLD. If you don’t-BUY.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed down $.10 at $2.50, still up 31% so far. IYXI released earnings last week. Another sizable loss-$9.8 million (it did have some special charges related to 2 pending acquisitions in there of about $3 million and non-cash stuff of another $2 million). Their bank debt is high and they have some issues there. Revenues were up 137% to $20.1 million. But if their predictions come true–profits in Q4 and $140 million in revenue next year this should soar. Risky because of the continued losses and debt load so HOLD.

This one is as “thin” as they get. I think it took me over a month to buy 15,000 shares.

But, ARI continues to grow sales and earnings every year, has gross margins over 80%, has net-cash of $.20 a share and a valuation of $5.21 a share. It is also profitable. So it is trading at 40% of valuation.

ARI does online catalogues and related services for manufactured equipment makers. They keep spewing out new customer and expanded customer relationship press releases and the the stock does nothing. This is just a steady, 3 yards and a cloud of dust growth company so far. But it is so far undervalued that I just couldn’t not recommend this anymore. When it is discovered, it should be a 50-100% gainer. BUY

Sorry we missed our update last week (don’t ask). We will update performance from 2 weeks ago, today.

We broke even over the last 2 weeks, 5 up, 5 down and 1 even. However, our model portfolio year-to-date gain dropped 3% to a 15% gain, mostly due to MIVA and OPTO.ob. MIVA is still our biggest dog, followed by DWCH, LINN.ob, PDLI and then OPTO.ob. Since the start of the year we are 9 up and 5 down. No buys or sells this past 2 weeks.

The model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

CAW-(Buy price $9.45, Valuation $18.40). Closed up $.27 for the week at $10.00. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. The company has rejected this offer. The company is “in-play”. CB owns 7.9% of the stock. No news last week on anything. Up 6% so far. HOLD.

QADI-(Buy price $6.93, Valuation $13.73 (was $11.86). Closed at $7.61, up $.01. QADI released earning last week–not bad. The valuation has moved up to $13.73, so at the current price it is trading at only 55% of valuation. Has $1.30 in cash also. Up 10% so far. BUY.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $18.39, up $.95 from last week. Now down only 5%. Volatile stock. BUY.

MIVA-(Buy price $3.80, Valuation $7.38 (was $9.10)). MIVA closed at $2.35, down $.48. Now down 38% on this one. MIVA released Q2 results week before last. They reported a whopping $73 million loss ($2.29 a share), but after deducting a BS goodwill write-off of $64 million and another $5.8 million of stock expense, severance and restucturing charges, they only lost about $3.5 million. This still stinks. The valuation sank to $7.38 from the previous $9.10, but the stock is still selling at only 32% of its valuation–and it has $1.16 a share in cash (49% of its market value). The risk here of course that the Googles and other search engines continue to eat MIVA’s lunch (like Walmart did to regional retailers). But at this price, I will be in there buying on Monday. BUY.

Datawatch-(Buy price $3.66, Valuation $7.63 (was $9.31)). Closed at $2.85, down $.11 from last week, still a loser–down 22%. HOLD.

Inforte-(Buy price $4.11, Valuation $6.86 (was $7.32)). Up $.22 to $4.22 last week. Still has $2.52 per share in cash and valuation only fell a little, but lowering our price objective to $5.50. Now up 3%. BUY.

OB-abies

Linn.ob-(Buy price $.36, Valuation $.66 (was $.79)). Closed at $.31, up $.02. Still trading at less than 50% of our current valuation. Down 14% YTD. HOLD until we get some revenue growth and stop losing money.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.20, down $.10. They just keep announcing new customers and the market yawns and bids up Yahoo and Amazon. I’ll continue to skip those and stay with OPTO. Now down 4% to date. BUY.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock closed at $1.8), down $.09 from $1.89. Now only up 51%. Wainting on year-end results for AVSO. Could be burdened with some acquisition and capital raising charges, but we expect to see some good operating results. Still only trading at 50% of our valuation. BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $1.05 (Was $.82)). Ask price fell to $.37 (down $.05). Closed at $.34. Cash is $.28 per share. CTIG realeased earning also. Not great but (sales down a bit and had a book loss of $.01 per share) the valuation increased to $1.05 and net cash was $.26 per share. Up 37% (based on asked price). If you own this HOLD. If you don’t-BUY.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed at same price as 2 weeks ago– $2.60, still up 36% so far. HOLD

Although our losers outnumbered our winners last week, our model portfolio year-to-date gain nudged up 1% to 18% due to decent gains in AVSO.ob and IYXI.ob. MIVA is still our biggest dog, followed by Linn.ob, DWCH, PDLI and then INFT. Last week we had 2 up, 8 down and 1 even. Since the start of the year we are 9 up and 5 down. No buys or sells this past week.
Our model portfolio based on the stocks in this Blog is up 18% so far this year (up 1% from last week). This model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.02 for the week at $9.73. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. The company has rejected this offer. The company is “in-play”. CB owns 7.9% of the stock. No news last week on anything. Up 3% so far. HOLD.

QADI-(Buy price $6.93, Valuaton $11.86). Closed at $7.60, down $.03. Up 10% so far. HOLD.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $17.44, down $.93 from last week. Now down 10%. PDLI announced earnings last week. GAAP loss, Non-GAAP profit. They are now generating $200 million a year in royalties which alone is almost worth the current market cap. They lost one clinical candidate that they acquired last year–don’t see this as a big deal. Big drugs in the pipeline, royalties are growing. This is still a BUY.

MIVA-(Buy price $3.80, Valuation $9.10). MIVA closed at $2.83, down $.11 from last week. Now down 26% on this one. HOLD.

Datawatch-(Buy price $3.66, Valuation $7.63 (was $9.31). Closed at $2.96, down $.09 from last week, still a loser–down 19%. HOLD.

Inforte-(Buy price $4.11, Valuation $6.86 (was $7.32). Down $.25 to $4.00 last week. Still has $2.52 per share in cash and valuation only fell a little, but lowering our price objective to $5.50. Now down 3%. BUY.

OB-abies

Linn.ob-(Buy price $.36, Valuation $.66 (was $.79). Closed at $.29, even on the week. Linn announced earnings last week, had a small loss of about $150,000, excluding special items. Volume in the stock soared last week and we saw some sizable bids (like 80,000 shares) which is encouraging. Still trading at less than 50% of our current valuation. Down 19% YTD. HOLD until we get some revenue growth and stop losing money.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.30, down $.10 from last week. Now up 4% to date. HOLD.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock rebounded last week to $1.89, up $.26 from $1.53. Now only up 59%. Not as cheap as last week, but still only trading at 50% of our valuation. BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $.82). Ask price fell to $.42 (down $.02) last week. Closed at $.42. Cash is $.28 per share. Up 56% (based on asked price). HOLD.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed up $.11 from last week at $2.60, up 36% so far. HOLD

No luck on the earnings front. DWCH and INFT dissapointed. MIVA is our biggest dog, followed by Linn.ob, DWCH and then PDLI. Last week we had 5 up, 6 down. Since the start of the year we are still 10 up and 4 down. No buys or sells this past week.

Our model portfolio based on the stocks in this Blog is up 17% so far this year. Not as good as we would like, but not bad given the choppy market and 4 losers we have right now (we shoot for 80% win rate–not our current 71%). This model portfolio assumes $10,000 invested in each stock, less $10 commission each way (TD Ameritrade rate).

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.03 for the week at $9.75. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. The company has rejected this offer. The company is “in-play”. CB owns 7.9% of the stock. Up 3% so far. HOLD.

QADI-(Buy price $6.93, Valuaton $11.86). Closed at $7.63, up $.29. Up 10% so far. HOLD.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $18.37, up $1.86 from last week. Now down 5%. Still a BUY.

MIVA-(Buy price $3.80, Valuation $9.10). MIVA closed at $2.94, up $.19 from last week. Now down 23% on this one. HOLD.

Datawatch-(Buy price $3.66, Valuation $7.63 (was $9.31). Closed at $3.05, down $.56 from last week, still a loser–down 17%. See our previous post. HOLD.

Inforte-(Buy price $4.11, Valuation $6.86 (was$7.32). Down $.52 to $4.25 last week. Still has $2.52 per share in cash and valuation only fell a little, but lowering our price objective to $5.50. Now up only 3%. HOLD.

OB-abies

Linn.ob-(Buy price $.36, Valuation $.79). Closed at $.29, down $.03. Now down 19% YTD. HOLD–let’s see what earning look like.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.40, up $.17 from last week. Now up 12% to date. HOLD.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock fell another $.28 from last week to $1.53. Now only up 29%. This looks like steal here–BUY.

CTIG.ob-(Buy price $.27 ask, Valuation $.82). Ask price rose to $.44 (up $.01) last week. Closed at $.42. Cash is $.28 per share. Up 63% (based on asked price). Bid price was up to $.42. HOLD.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed down $.11 from last week at $2.49, up 30% so far. HOLD

DWCH released 6/30 results this morning. Dissappointing to say the least. Sales were down from last year despite the recent acquisition being in effect for 2 months of the quarter. Stock got hammered on low volume (22,000 shares right now) down as low as $2.51. Seems to be rising a bit now, but big damage has been done. Lost $315,000 for the quarter–merger related expenses cited–but not how much. New valuation has come down to $7.63–still, at this price the discount to valuation says hold, and maybe buy more and average down a bit. Think this is an overreaction in a “thin” stock.

Our worst week of the year. Despite the brief rally in the markets, down, is the direction. Hopefully some good earning reports will appear for our stocks in the next couple of weeks and we will get some upwards pops. MIVA is our biggest dog, but PDLI is catching up. Last week we had 1 up, 9 down. CAW is looking interesting (see below). Since the start of the year we are still 9 up and 5 down. No buys or sells this past week. Looking at a number of stocks that look cheap–and they continue to get cheaper the longer we wait. We would rather miss them than make a mistake.

CAW-(Buy price $9.45, Valuation $18.40). Closed down $.20 for the week at $9.78. Yield about 3%. A group called Costa Brava Partnership is offering to buy the Class A stock at a “substantial premium”. Hopefully this is the catalyst we have been waitng for. CB owns 7.9% of the stock. Maybe management will do something for us shareholders to unlock the value here. Up 3% so far. HOLD.

QADI-(Buy price $6.93, Valuaton $11.86). Closed at $7.34, down $.36. Up 11% so far. HOLD.

PDLI-(Buy price $19.31, Valuation > $30)–Closed at $16.51, down $.75 from last week. Now down 15%. Still a BUY.

MIVA-(Buy price $3.80, Valuation $9.10). MIVA closed at $2.75, down $.05 from last week. Now down 28% on this one. HOLD.

Datawatch-(Buy price $3.66, Valuation $9.31). Closed at $3.61, up $.01 from last week, still a loser–down 1%. The discount to the valuation is just too big. Still a BUY.

Inforte-(Buy price $4.11, Valuation $7.32). Down $.02 to $4.77 last week. Still up 16%. HOLD for $6.00.

OB-abies

Linn.ob-(Buy price $.36, Valuation $.79). Closed at $.32, down $.04. Now down 11% YTD. Still a BUY.

OPTO.ob-(Buy price $1.25, Valuation $2.88). Closed at $1.23, down $.03 from last week. Now down 2% to date. BUY.

AVSO.ob-(Buy price $1.19, Valuation $3.81). Stock fell another $.14 from last week to $1.81. Now only up 52%. BUY

CTIG.ob-(Buy price $.27 ask, Valuation $.82). Ask price fell to $.43 (down $.02) last week. Closed at $.43. Cash is $.28 per share. Up 59% (based on asked price). HOLD.

IYXI.ob-(Buy price $1.91, Valuation–over $3.00). Closed down $.05 from last week at $2.60, up 36% so far. Announced some new business deals last week, but nobody cared. HOLD